Tag: CORO
Free Spike Antigen ID’d in Post-SARS-CoV-2 mRNA Vaccine Myocarditis
However, mRNA vaccine-induced immune responses did not differ for those who developed myocarditis and those who did not
MIS-C Seems More Common, Severe Than Previously Thought
Racial disparities seen in outcomes, including more cases in Black children as organ dysfunction increases
VV116 Noninferior to Nirmatrelvir-Ritonavir for COVID-19
Noninferiority established with respect to time to sustained clinical recovery for adults at high risk for progression
Racial/Ethnic Variation Seen in COVID-19 Vaccination Status in Children
Non-Hispanic Asian children and adolescents have the highest vaccination coverage, followed by Hispanic/Latino children
Increasing Staff Vaccination at Nursing Homes Cuts COVID-19 Infections
Increase in vaccination rate linked to fewer COVID-19 cases and deaths among residents, cases among staff
Risk for SARS-CoV-2 Breakthrough Infection Increased for Cancer Patients
Risk for severe outcomes of COVID-19 higher for patients with hematologic versus solid cancer
No Increase in Adverse Events Seen With COVID-19 Vaccination After MIS-C
Minor adverse events seen in 48.6 percent of patients, most often arm soreness and/or fatigue
COVID-19 Booster mRNA Dose Increases Antibody Duration
Immunoglobulin G spike receptor binding domain antibody levels similar after primary series, booster dose
U.S. to Require Negative COVID-19 Test For Chinese Visitor Entry
The new rule, set to go into effect on Jan. 5, was created in response to a surge in COVID-19 cases in China
Molnupiravir Does Not Reduce COVID-19-Related Hospitalization, Death
No reduction in COVID-19-associated hospitalizations or deaths seen among high-risk, vaccinated adults
